Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q34475645
Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control studyAstrocytes and therapeutics for Parkinson's disease.Neurotoxic effects of tetrahydroisoquinolines and underlying mechanismsThe organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors.Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes.Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium.4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.
P2860

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q34475645
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
type
label
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
altLabel
Isoquinoline derivatives as en ...... tiology of Parkinson’s disease
@en
prefLabel
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
P2093
P304
P31
P356
10.1016/S0006-2952(98)00142-7
P407
P433
P478
P50
P577
P698
P921